Erythema Nodosum-like Eruption in the Setting of Sorafenib Therapy

JAMA Dermatol. 2018 Mar 1;154(3):369-370. doi: 10.1001/jamadermatol.2017.5733.

Authors

Emily L Coleman¹, Shawn E Cowper^{1

2}, Stacey M Stein³, Jonathan S Leventhal¹

Affiliations

¹ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
² Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
³ Department of Medicine Medical Oncology, Yale University School of Medicine, New Haven, Connecticut.

PMID: 29453869
DOI: 10.1001/jamadermatol.2017.5733

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenomatous Polyposis Coli / drug therapy*
Aged
Antineoplastic Agents / adverse effects*
Duodenal Neoplasms / drug therapy*
Erythema Nodosum / chemically induced*
Erythema Nodosum / diagnosis
Erythema Nodosum / pathology
Female
Fibroma / drug therapy*
Humans
Middle Aged
Neoplasms, Multiple Primary / drug therapy*
Pancreatic Neoplasms / drug therapy*
Sorafenib / adverse effects*

Substances

Antineoplastic Agents
Sorafenib